09
Mar 26
Regulatory Intelligence Sharing
HKAPI Regulatory Affairs Working Group (RAWG) hosted a "Regulatory Intelligence Sharing" session on 9 March 2026.
29
Jan 26
2026 GBA Real-world Research and Application Forum
Co‑organized with GBAICTI and its key facility RWSAC, the 2026 GBA Real-world Research and Application Forum brought together representatives from government, regulatory authorities, academia, and industry across overseas, the Chinese Mainland and GBA, including Hong Kong.
06
Dec 25
Learning from Neighbours: Fostering an Eco-system for Medical and Pharmaceutical Advancement
The “Learning from Neighbours” forum successfully resumed after Covid, focusing on the theme “Fostering an Eco-system for Medical and Pharmaceutical Advancement.”
10
Jul 25
Regulatory Briefing Session on CMPR & “1+” Mechanism
To help members understand the latest policy, the HKAPI Regulatory Affairs Working Group held a workshop on July 10, 2025, focusing on the CMPR's strategic plan and the "1+" mechanism.
12
Feb 25
Visiting GBAICTI: Paving the Way for Cross-Boundary Clinical Trials
On 12 February 2025, around 30 delegates from 20 member companies visited GBAICTI and HTCZ.
27
Jan 25
Welcome Bloomberg as HKAPI’s Catalyst Member
We are delighted to welcome Bloomberg as a Catalyst Member of the Hong Kong Association of the Pharmaceutical Industry (HKAPI).
22
Oct 24
GBA Real-world Research Forum to explore opportunities in research and applications
Aiming to develop an ecosystem for RWD, HKAPI and RDPAC co-organized “2024 GBA Real-world Research Forum” on 22 October, at the Guangzhou International Bio-Island.
